Keros Therapeutics (KROS) Shares Issued (2019 - 2025)
Keros Therapeutics posted quarterly Shares Issued of $117000.0 for Q3 2025, up 101.35% year-on-year from $58108.7 in Q3 2024, and up 588.24% on a QoQ basis from $17000.0 in Q2 2025.
Keros Therapeutics (KROS) has 7 years of Shares Issued data on file, last reported at $117000.0 in Q3 2025.
- For the quarter ending Q3 2025, Shares Issued rose 101.35% year-over-year to $117000.0; the trailing twelve-month figure through Dec 2025 stood at $138000.0 (down 98.86% YoY), and the FY2025 full-year result was $138000.0, down 98.86% from the prior year.
- Shares Issued for Q3 2025 stood at $117000.0, up from $17000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $48.5 million in Q3 2022 and bottomed at -$57.4 million in Q4 2022.
- The 5-year median for Shares Issued is $311000.0 (2023), against an average of $879000.0.
- Peak annual rise in Shares Issued reached 49076.77% in 2022, while the deepest fall reached 15234.3% in 2022.
- A 5-year view of Shares Issued shows it stood at $379000.0 in 2021, then slumped by 15234.3% to -$57.4 million in 2022, then surged by 101.4% to $804000.0 in 2023, then jumped by 1410.07% to $12.1 million in 2024, then plunged by 99.04% to $117000.0 in 2025.
- The last three Shares Issued figures came in at $117000.0 (Q3 2025), $17000.0 (Q2 2025), and $4000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 117,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 12.14 Mn |
| Dec 31, 2024 | 12.14 Mn |
| Sep 30, 2024 | -8.69 Mn |
| Sep 30, 2024 | -8.69 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Dec 31, 2023 | 804,000.00 |
| Dec 31, 2023 | 804,000.00 |
| Sep 30, 2023 | 311,000.00 |
| Sep 30, 2023 | 311,000.00 |
| Jun 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 1.74 Mn |
| Mar 31, 2023 | 370,000.00 |
| Mar 31, 2023 | 370,000.00 |
| Dec 31, 2022 | -57.36 Mn |
| Dec 31, 2022 | -57.36 Mn |
| Sep 30, 2022 | 48.49 Mn |
| Sep 30, 2022 | 48.49 Mn |
| Jun 30, 2022 | 9.57 Mn |
| Jun 30, 2022 | 9.57 Mn |
| Mar 31, 2022 | 118,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Dec 31, 2021 | 379,000.00 |
| Dec 31, 2021 | 379,000.00 |
| Sep 30, 2021 | -99,000.00 |
| Sep 30, 2021 | -99,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 9,000.00 |
| Mar 31, 2020 | 13,000.00 |
| Mar 31, 2020 | 13,000.00 |
| Dec 31, 2019 | -10,000.00 |
| Dec 31, 2019 | -10,000.00 |
| Sep 30, 2019 | 6,000.00 |
| Sep 30, 2019 | 6,000.00 |
| Jun 30, 2019 | 4,000.00 |
| Jun 30, 2019 | 4,000.00 |